Healthcare

PRODUCTS

  • Purpose-built with users at the center to make it easier and more efficient to get quality patient outcomes data for submissions and approvals.

    Collecting quality data on patient outcomes is often one of the most important parts of a clinical trial. It is also challenging, and many eCOA solutions make it feel even more difficult with complicated processes, lack of questionnaire reusability, slow set up, and difficult to use tech.

  • UNICORN™ control software offers real-time control of protein purification unit operations (column packing and chromatography) from laboratory bench, through development, to full-scale production. UNICORN™ control system meets the needs of full-scale production with manufacturing systems while maintaining the flexibility needed for method and process development with the range of systems in the ÄKTA™ family.

  • Find the missing links

    The modular DMi8 inverted microscope is the heart of the DMi8 S platform solution. For routine to live cell research, the DMi8 S platform is a complete solution. Whether you need to precisely follow the development of a single cell in a dish, screen through multiple assays, obtain single molecule resolution, or tease out behaviors of complex processes, a DMi8 S system will enable you to see more, see faster, and find the hidden.

    • See more – Increase your viewing area up to 10,000x
    • See faster – Experiments up to 5x faster
    • See the hidden – Activate, ablate, and bleach within one experiment
  • Qosina offers the largest selection of surgical sterilization supplies to meet your needs.

  • By removing barriers, and bringing trials to patients where they live, we can expand the geographical reach of clinical research across the globe allowing more patients to participate. Our patient-centric delivery means we can create convenience and comfort working the schedule of the trial around the schedule of the patient and their family, not the other way around. This approach provides important access to medical care, enhances the inclusivity of clinical trials and advances drug development for all.

WHITE PAPERS AND CASE STUDIES

NEWS